Boy who died 450 years ago gives clues to hepatitis research
(HealthDay)— The mummified remains of an Italian boy who died 450 years ago suggest the hepatitis B virus has infected humans for centuries.
Jan 4, 2018
0
3
(HealthDay)— The mummified remains of an Italian boy who died 450 years ago suggest the hepatitis B virus has infected humans for centuries.
Jan 4, 2018
0
3
Reducing chronic hepatitis B infections by screening at-risk adults, increasing hepatitis B vaccination rates, and linking infected persons to care is a public health priority, the American College of Physicians (ACP) and ...
Nov 20, 2017
0
0
(HealthDay)—Elevated levels of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) are associated with increased risks of liver cancer, according to a study published online Oct. 24 in the Journal of Gastroenterology ...
Nov 1, 2017
0
0
As public health officials worry that the increase of opioid use among young adults has helped to spread the hepatitis C virus to a new generation, a study in Rhode Island finds that while screening is common, the follow-up ...
Oct 25, 2017
0
0
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.
Oct 20, 2017
0
0
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...
Oct 13, 2017
0
45
(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...
Oct 12, 2017
0
0
Valerie Green is still waiting to be cured.
Oct 11, 2017
0
2
A new article published by JAMA Oncology reports the results of the Global Burden of Disease 2015 study on primary liver cancer incidence, death and years of healthy life lost in 195 countries or territories from 1990 to ...
Oct 5, 2017
0
0
Arrowhead Pharmaceuticals today announced results from studies of ARC-520, a prior-generation RNAi therapeutic candidate against chronic hepatitis B virus (HBV) infection, in a Phase 2 clinical study in HBV patients and a ...
Sep 27, 2017
0
3